Sponsor or institution
Clinical trials and research at Beneficência Portuguesa de São Paulo
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Beneficência Portuguesa de São Paulo that are recruiting, in Brazil. By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pharmacogenomic panel to predict chemotherapy- and immunotherapy-induced heart damage | — | Fortaleza, Ceará and 5 other locations | Recruiting | Jun 23, 2026 |
| Using blood markers to improve treatment for metastatic pancreatic cancer | — | São Paulo, São Paulo | Recruiting | Apr 27, 2025 |
| Preventing type 2 diabetes in high-risk adults in Brazil | — | Goiânia, Goiás and 1 other locations | Recruiting | May 23, 2024 |
| Comparing Ceftolozane/Tazobactam and Meropenem for Febrile Neutropenia in Patients at Risk for ESBL Infections | Phase 4 | São Paulo | Recruiting | Apr 2, 2024 |
All recruiting trials (4)
-
Pharmacogenomic panel to predict chemotherapy- and immunotherapy-induced heart damage
A pharmacogenomic and pharmacoepigenetic panel is being tested to see if it can predict which breast cancer patients will develop heart damage from chemotherapy or immunotherapy.
-
Using blood markers to improve treatment for metastatic pancreatic cancer
This study is testing if analyzing certain blood markers can help doctors better tailor treatments for patients with advanced pancreatic cancer starting a specific chemotherapy regimen.
-
Preventing type 2 diabetes in high-risk adults in Brazil
This study is testing a diabetes prevention program in Brazil to see if it can help high-risk adults avoid developing type 2 diabetes over three years.
-
Comparing Ceftolozane/Tazobactam and Meropenem for Febrile Neutropenia in Patients at Risk for ESBL Infections
This study is testing if a new antibiotic called Ceftolozane/Tazobactam works just as well as Meropenem for people with febrile neutropenia who are at risk for certain infections.
Quick answers
How many clinical trials run by Beneficência Portuguesa de São Paulo are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Brazil. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.